ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 345 filers reported holding ENCOMPASS HEALTH CORP in Q3 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $418,537 | +4.4% | 6,231 | +5.2% | 0.08% | +2.5% |
| Q2 2023 | $400,885 | +25.7% | 5,921 | +0.5% | 0.08% | +22.7% |
| Q1 2023 | $318,834 | +19.1% | 5,893 | +31.6% | 0.07% | +15.8% |
| Q4 2022 | $267,785 | +31.3% | 4,477 | +23.1% | 0.06% | +18.8% |
| Q2 2022 | $204,000 | -32.9% | 3,637 | -15.1% | 0.05% | -20.0% |
| Q1 2022 | $304,000 | +18.8% | 4,282 | +9.2% | 0.06% | +25.0% |
| Q4 2021 | $256,000 | -16.9% | 3,922 | -4.4% | 0.05% | -23.8% |
| Q3 2021 | $308,000 | +0.3% | 4,101 | +4.2% | 0.06% | 0.0% |
| Q2 2021 | $307,000 | -5.0% | 3,934 | -0.4% | 0.06% | -10.0% |
| Q1 2021 | $323,000 | +2.5% | 3,948 | +3.6% | 0.07% | -10.3% |
| Q4 2020 | $315,000 | – | 3,811 | +3.4% | 0.08% | – |
| Q3 2020 | $0 | -100.0% | 3,684 | +1.7% | 0.00% | -100.0% |
| Q2 2020 | $224,000 | 0.0% | 3,624 | +12.3% | 0.07% | +3.1% |
| Q4 2019 | $224,000 | – | 3,228 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |